Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Voxox Endorses The Dr. Alfonsina Q. Davies Epilepsy Foundation
  • USA - English


News provided by

Voxox

Jun 10, 2015, 09:00 ET

Share this article

Share toX

Share this article

Share toX

Alfonsina ("Nina") Q. Davies
Alfonsina ("Nina") Q. Davies

SAN DIEGO (PRWEB) June 10, 2015 -- Voxox®, the most comprehensive cloud-based rich communication service for consumers and businesses, today announced its endorsement of the Dr. Alfonsina Q. Davies Epilepsy Foundation. Voxox has been an advocate for the organization in a variety of ways, including volunteering marketing, design, and event management resources to help promote the cause. Voxox is encouraging its community to support this new foundation in meeting its epilepsy research, treatment and awareness objectives.

'As a business operated by a father and three brothers, Voxox is particularly attuned to the importance of family, and this cause spoke to us because life-long illnesses, such as epilepsy, are debilitating to families.' - Bryan Hertz, CEO of Voxox.

Post this

The Dr. Alfonsina Q Davies Epilepsy Foundation was formed by Thomas and Nadia Davies in honor of their daughter, Dr. Alfonsina ("Nina") Quintana Davies, who had epilepsy from birth. Nina Davies suffered with the disorder for 52 years, ultimately succumbing to SUDEP (sudden unexpected death in epilepsy). Most people are not aware that epilepsy kills more Americans than breast cancer (Epilepsy.com; Cancer Facts & Figures 2015). After Nina’s passing, Thomas and Nadia Davies have pledged their lives to help those afflicted with epilepsy. Among other initiatives, they have instituted an Academic Chair for Research in Epilepsy at the University of California, Los Angeles. Dr. Gary Mathern, professor of pediatric neurosurgery and director of the UCLA Pediatric Epilepsy Program at Mattel Children's Hospital has been appointed to the Chair.

"We at Voxox have been incredibly touched by the Davies family story and Nina's courageous battle with epilepsy," said Bryan Hertz, CEO of Voxox. "As a business operated by a father and three brothers, Voxox is particularly attuned to the importance of family, and this cause spoke to us because life-long illnesses, such as epilepsy, are debilitating to families. We invite our community to consider supporting the Dr. Alfonsina Q. Davies Epilepsy Foundation."

The foundation has three core goals and donation initiatives:

• Increase the research that is being conducted to treat and cure epilepsy through the Dr. Alfonsina Q. Davies Endowed Chair for Research in Epilepsy, established at UCLA. It is the only Academic Chair at UCLA for this purpose.
• Establish the “Dr. Alfonsina Q. Davies Epilepsy Treatment Center” at a major university medical center. Current practice in epilepsy treatment is to focus on the disorder and treat it through medication, implant or surgery, but not all epilepsy patients can have their seizure disorder significantly suppressed or eliminated. The center will be staffed with counselors, social workers, psychologists and psychiatrists who specialize in the treatment of those with epilepsy.
• Create empathy in the general public for those with epilepsy. One in ten Americans will have a seizure in their lifetime (Epilepsy.com) and one in 26 will develop epilepsy (Epilepsy Across The Spectrum). Unlike other illnesses the psychosocial trauma that individuals with seizures suffer impacts their lives almost as much as the seizures themselves. One of the foundation's goals is to diminish the stigma and discrimination that is associated with epilepsy today.

"Our Nina was treated for seizures all of her life, but we were never able to find someone that understood or could treat her for the emotional distress that she lived with everyday, fearing a seizure in public and the consequences it would bring," said Thomas Davies, PhD. "We would like to help people 'walk in the shoes' of someone with epilepsy, and we hope that our foundation's programs and future plans will make progress."

To learn more about epilepsy and the Dr. Alfonsina Q. Davies Epilepsy Foundation programs, please visit http://ninascourage.org/foundation-outreach/. If you wish to support this foundation you can find all the pertinent information at http://ninascourage.org/donations. All donations are tax deductible.

About Voxox
Voxox is an innovator in unified cloud communication solutions for consumers and businesses. For consumers and its operator partners, Voxox delivers cutting-edge mobile and desktop applications that integrate voice, video, messaging, fax, media sharing and more. For businesses, Voxox provides an extensive suite of carrier-grade business phone solutions, including hosted IP-PBX, SIP Trunking, a wide array of wholesale services, such as high volume SMS, and the company's new virtual PBX service, Cloud Phone. The foundation of the company’s offerings is its award-winning unified communications platform in the cloud, which enables the company and its customers to build powerful, scalable applications and services. Founded in 2006, Voxox is headquartered in San Diego. For more information, please visit http://www.voxox.com.

Natasha Grach, Voxox, http://www.voxox.com, +1 (619) 798-0043, [email protected]

Modal title

Alfonsina ("Nina") Q. Davies
Alfonsina ("Nina") Q. Davies
NinasCourage.org website homepage
NinasCourage.org website homepage
Credit: Carlos Grangel; Copyright 2014, Thomas P. and Nadia Q. Davies, Trustees, The Dr. Alfonsina Q. Davies Epilepsy Foundation.
Credit: Carlos Grangel; Copyright 2014, Thomas P. and Nadia Q. Davies, Trustees, The Dr. Alfonsina Q. Davies Epilepsy Foundation.
Alfonsina ("Nina") Q. Davies NinasCourage.org website homepage Credit: Carlos Grangel; Copyright 2014, Thomas P. and Nadia Q. Davies, Trustees, The Dr. Alfonsina Q. Davies Epilepsy Foundation.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.